Alternative Medicine Issue 37 September, 2000
Hyperthermia (InfraRed) and Electrotherapy
By Harvey Kaltsas, D.O.M.,A.P.
Prostate Cancer
Another one of Dr. Douwes' many success stories is Les M., an engineer from California who had prostate cancer. From his professional education he brings a skeptical, inquiring, scientific perspective to viewing various situations. Before Les came to Klinik St. Georg for transurethal prostate hyperthermia treatment, he carefully reviewed the literature on different treatments. He chose the clinic after learning that local-region radio-wave hyperthermia has produced "fabulous results" (whereas the U.S. study of hyperthermia using microwaves cause patients agonizing urethral pain and made U.S. doctors thereafter shun the procedure). Les was also impressed to learn how sophisticated the clinic's method of determining efficacy of treatment is. The traditional Prostate-Specific Antigen (PSA) test gives a high rate of false negatives (about 30%). Les had a particular from of aggressive form of aggressive prostate cancer that is not revealed by elevated PSA's. Klinik St. Georg also uses the Polymerase Chain Reaction (PCR) technique to determine whether cancer cells are still circulating in the blood stream.
When I met Les just before he was to go in for his first treatment. He sat in a comfortable upholstered chair with flexible radio-receiving plates affixed to each buttock. With local anesthesia he had a probe containing a tiny radio transmitter introduced through a transurethral catheter into his enlarged prostate. Unlike the American protocol, which used high-energy microwaves that burned both cancerous and non-cancerous tissue alike, the Klinik St. Georg treatment employs short-wave radio transmissions. These heat the prostate area to between 113 and 158 degrees Fahrenheit and adversely affect only malignant cells. At times Les felt some discomfort during the treatment, as if he had to urinate, but otherwise the three-hour process was not traumatic, and he was asleep for much of the time. I interviewed Les fifteen minutes post-therapy, after his catheter was removed and he had urinated without pain or any burning sensation. He was positively joyful and downright playful.
I received a call from Les Two months later, just as I was finishing writing this article. He had to tell me that he had just visited his previous two conventional oncologists. They performed the ultrasound imaging and digital rectal palpation that had revealed his cancer in the first place (later confirmed by biopsy). They found nothing: there was no evidence of cancer left. They could not perform a follow-up biopsy because there was no mass left to target.